Skip to NavigationSkip to content

News

0
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the first case occurring in US borders,...
0
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the recommendation of Astellas’ Xospata (...
0
Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its efficacy in the...
0
China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the US, Canada and Europe.

Features

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...